Institute of Acupuncture and Anesthesia, Shanghai Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China
South London and Maudsley NHS Foundation Trust, London, UK.
BMJ Open. 2020 Jan 7;10(1):e031927. doi: 10.1136/bmjopen-2019-031927.
To identify predictors of recurrent cerebrovascular morbidity in a cohort of patients with depression and a cerebrovascular disease (CBVD) history.
We used the Maudsley Biomedical Research Centre Case Register to identify patients aged 50 years or older with a diagnosis of depressive disorder between 2008 and 2017 and a previous history of hospitalised CBVD. Using depression diagnosis as the index date we followed patients until first hospitalised CBVD recurrence or death due to CBVD. Sociodemographic data, symptom and functioning scores of Health of the Nation Outcome Scales, medications and comorbidities were extracted and modelled in multivariate survival analyses to identify predictors of CBVD reoccurrence.
Of 1292 patients with depression and CBVD (mean age 75.6 years; 56.6% female), 264 (20.4%) experienced fatal/non-fatal CBVD recurrence during a median follow-up duration of 1.66 years. In multivariate Cox regression models, a higher risk of CBVD recurrence was predicted by older age (HR, 1.02; 95% CI, 1.01 to 1.04) (p=0.002), physical health problems (moderate to severe HR, 2.47; 95% CI, 1.45 to 4.19) (p=0.001), anticoagulant (HR, 1.40; 95% CI, 1.01 to 1.93) (p=0.041) and antipsychotic medication (HR, 0.66; 95% CI 0.44 to 0.99) (p=0.047). Neither depression severity, mental health symptoms, functional status, nor antidepressant prescribing were significantly associated with CBVD recurrence.
Approximately one in five patients with depression and CBVD experienced a CBVD recurrence over a median follow-up time of 20 months. Risk of CBVD recurrence was largely dependent on age and physical health rather than on severity of depressive symptoms, co-morbid mental health or functional problems, or psychotropic prescribing.
确定有抑郁病史和脑血管疾病(CBVD)病史的患者群体中复发性脑血管发病率的预测因素。
我们使用莫兹利生物医学研究中心病例登记处,确定了 2008 年至 2017 年间年龄在 50 岁及以上、有诊断为抑郁障碍和既往有住院 CBVD 病史的患者。以抑郁诊断为索引日期,我们对患者进行随访,直至首次发生住院 CBVD 复发或因 CBVD 死亡。提取并在多变量生存分析中对社会人口统计学数据、国民健康结果量表的症状和功能评分、药物和合并症进行建模,以确定 CBVD 再发的预测因素。
在 1292 例有抑郁和 CBVD 的患者中(平均年龄 75.6 岁,56.6%为女性),264 例(20.4%)在中位随访 1.66 年期间发生致命/非致命性 CBVD 复发。在多变量 Cox 回归模型中,年龄较大(HR,1.02;95%CI,1.01 至 1.04)(p=0.002)、身体健康问题(中度至重度 HR,2.47;95%CI,1.45 至 4.19)(p=0.001)、抗凝药物(HR,1.40;95%CI,1.01 至 1.93)(p=0.041)和抗精神病药物(HR,0.66;95%CI,0.44 至 0.99)(p=0.047)与 CBVD 复发的风险较高相关。抑郁严重程度、心理健康症状、功能状态或抗抑郁药物的使用与 CBVD 复发均无显著相关性。
在中位随访时间为 20 个月期间,约五分之一有抑郁和 CBVD 的患者发生 CBVD 复发。CBVD 复发的风险主要取决于年龄和身体健康状况,而不是抑郁症状严重程度、合并心理健康或功能问题或精神药物的使用情况。